This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Karen Wood, The Ohio State University
ClinicalTrials.gov Identifier:
NCT01420172
First received: August 16, 2011
Last updated: February 24, 2017
Last verified: October 2015
  Purpose

This will be a retrospective study and analysis of subjects who have undergone a hematopoietic stem transplant (either at OSUMC or external location) and were seen at OSUMC at any time between 01Jan2000 and 30Jun2011.

This study will determine factors influencing pulmonary disease and associated treatment strategies.


Condition Intervention
Post Hematopoietic Stem Cell Transplantation Other: Data Collection

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Resource links provided by NLM:


Further study details as provided by Karen Wood, The Ohio State University:

Primary Outcome Measures:
  • A retrospective diagnostic review on pulmonary disease related to hematopoietic stem cell transplantation. [ Time Frame: Up to 15 years ]
    To determine factors influencing pulmonary disease related to HSCT.


Secondary Outcome Measures:
  • A retrospective treatment review on treatment strategies for pulmonary disease related to hematopoietic stem cell transplantation. [ Time Frame: Up to 15 years ]
    To review treatment strategies for pulmonary disease post transplant for effectiveness.


Enrollment: 200
Study Start Date: August 2011
Study Completion Date: July 8, 2016
Primary Completion Date: July 8, 2016 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Post hematopoietic stem cell transplantation
Patients who were seen post hematopoietic stem cell transplantation between 01Jan2000 and 30Jun2011
Other: Data Collection
Collection of data on patients who were seen at OSUMC at any time between 01Jan2000 and 30Jun2011 post hematopoietic stem cell transplantation

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
A patient record captured during 01Jan2000 and 30Jun2011 from the medical record at The Ohio State University Medical Center who were seen post hematopoietic stem transplant.
Criteria

Inclusion Criteria:

  • Adult patients who have undergone a hematopoietic stem transplant (either at OSUMC or external location) and were seen at OSUMC at any time between 01Jan2000 and 30Jun2011.
  • Age > 18 years

Exclusion Criteria:

  • Age <18 years
  • Prisoners
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01420172

Locations
United States, Ohio
The Ohio State University Medical Center
Columbus, Ohio, United States, 43221
Sponsors and Collaborators
Karen Wood
  More Information

Publications:
Responsible Party: Karen Wood, MD, The Ohio State University
ClinicalTrials.gov Identifier: NCT01420172     History of Changes
Other Study ID Numbers: 2011H0214
Study First Received: August 16, 2011
Last Updated: February 24, 2017

Additional relevant MeSH terms:
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on June 22, 2017